BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36483382)

  • 1. Prevalence and microbiological and genetic characteristics of multidrug-resistant
    Sid Ahmed MA; Abdel Hadi H; Abu Jarir S; Ahmad Khan F; Arbab MA; Hamid JM; Alyazidi MA; Al-Maslamani MA; Skariah S; Sultan AA; Al Khal AL; Söderquist B; Ibrahim EB; Jass J; Ziglam H
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e96. PubMed ID: 36483382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant
    Sid Ahmed MA; Hamid JM; Husain AA; Hadi HA; Skariah S; Sultan AA; Ibrahim EB; Al Khal AL; Soderquist B; Jass J; Omrani AS
    Ann Med; 2021 Dec; 53(1):2345-2353. PubMed ID: 34882052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar.
    Sid Ahmed MA; Khan FA; Sultan AA; Söderquist B; Ibrahim EB; Jass J; Omrani AS
    Antimicrob Resist Infect Control; 2020 Nov; 9(1):170. PubMed ID: 33131487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar.
    Sid Ahmed MA; Abdel Hadi H; Hassan AAI; Abu Jarir S; Al-Maslamani MA; Eltai NO; Dousa KM; Hujer AM; Sultan AA; Soderquist B; Bonomo RA; Ibrahim EB; Jass J; Omrani AS
    J Antimicrob Chemother; 2019 Dec; 74(12):3497-3504. PubMed ID: 31504587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Multidrug- and Pandrug- Resistant
    Sid Ahmed MA; Hassan AAI; Abu Jarir S; Abdel Hadi H; Bansal D; Abdul Wahab A; Muneer M; Mohamed SF; Zahraldin K; Hamid JM; Alyazidi MA; Mohamed M; Sultan AA; Söderquist B; Ibrahim EB; Jass J
    Infect Prev Pract; 2019 Dec; 1(3-4):100027. PubMed ID: 34368684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of
    Sid Ahmed MA; Khan FA; Hadi HA; Skariah S; Sultan AA; Salam A; Al Khal AL; Söderquist B; Ibrahim EB; Omrani AS; Jass J
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of multidrug-resistant
    AbdulWahab A; Zahraldin K; Sid Ahmed MA; Jarir SA; Muneer M; Mohamed SF; Hamid JM; Hassan AAI; Ibrahim EB
    Lung India; 2017; 34(6):527-531. PubMed ID: 29098998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar.
    Abdel Hadi H; Dargham SR; Eltayeb F; Ali MOK; Suliman J; Ahmed SAM; Omrani AS; Ibrahim EB; Chen Y; Tsui CKM; Skariah S; Sultan A
    Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Diversity, Distribution, and Genomic Characterization of Antibiotic Resistance and Virulence of Clinical
    Kiyaga S; Kyany'a C; Muraya AW; Smith HJ; Mills EG; Kibet C; Mboowa G; Musila L
    Front Microbiol; 2022; 13():835403. PubMed ID: 35369511
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019.
    Karlowsky JA; Lob SH; Khan A; Chen WT; Woo PCY; Seto WH; Ip M; Leung S; Wong QW; Chau RWY; DeRyke CA; Young K; Motyl MR; Sahm DF
    J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451945
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods.
    Schaumburg F; Bletz S; Mellmann A; Becker K; Idelevich EA
    J Antimicrob Chemother; 2017 Nov; 72(11):3079-3084. PubMed ID: 28961968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Genome-Wide Analysis of an Isogenic Pair of
    Huang W; Hamouche JE; Wang G; Smith M; Yin C; Dhand A; Dimitrova N; Fallon JT
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporo-spatial variations in resistance determinants and clonality of Acinetobacter baumannii and Pseudomonas aeruginosa strains from Romanian hospitals and wastewaters.
    Gheorghe-Barbu I; Barbu IC; Popa LI; Pîrcălăbioru GG; Popa M; Măruțescu L; Niță-Lazar M; Banciu A; Stoica C; Gheorghe Ș; Lucaciu I; Săndulescu O; Paraschiv S; Surleac M; Talapan D; Muntean AA; Preda M; Muntean MM; Dragomirescu CC; Popa MI; Oțelea D; Chifiriuc MC
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):115. PubMed ID: 36104761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antimicrobial resistance in Gram-negative clinical isolates from a major secondary hospital in Kuwait: a retrospective descriptive study.
    Alali WQ; AlFouzan W; Dhar R
    Germs; 2021 Dec; 11(4):498-511. PubMed ID: 35096667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Activity of Colistin Against Contemporary (2015 - 2017)
    Zhang H; Zhang G; Zhang J; Duan S; Kang Y; Yang Q; Xu Y
    Front Microbiol; 2020; 11():1966. PubMed ID: 33013738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic and Temporal Patterns of Antimicrobial Resistance in
    Shortridge D; Gales AC; Streit JM; Huband MD; Tsakris A; Jones RN
    Open Forum Infect Dis; 2019 Mar; 6(Suppl 1):S63-S68. PubMed ID: 30895216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.